Questions About Cancer? 1-800-4-CANCER

Cervical Cancer Screening (PDQ®)

Health Professional Version

Changes to This Summary (11/25/2014)

Description of the Evidence

Added text about a second cluster-randomized trial of screening by visual inspection of the cervix with acetic acid (VIA) in low socioeconomic areas of urban Mumbai, India, that similarly demonstrated its efficacy in reducing cervical cancer mortality; after 12 years, the relative risk of dying from cervical cancer was reduced by 31% in the screening arm, corresponding to about 5 fewer deaths per 100,000 woman-years; compliance with treatment was about 15% lower for those in the control arm, which may have inflated the observed mortality benefit somewhat (cited Shastri et al. as reference 72).

This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

  • Updated: November 25, 2014